Advertisement
Canada markets closed

  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • CAD/USD

    0.7300
    +0.0003 (+0.03%)
     

  • CRUDE OIL

    82.73
    -0.08 (-0.10%)
     

  • Bitcoin CAD

    88,428.31
    -3,133.26 (-3.42%)
     

  • CMC Crypto 200

    1,394.99
    -29.11 (-2.04%)
     

  • GOLD FUTURES

    2,330.20
    -8.20 (-0.35%)
     

  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     

  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     

  • NASDAQ futures

    17,482.50
    -182.00 (-1.03%)
     

  • VOLATILITY

    15.97
    +0.28 (+1.78%)
     

  • FTSE

    8,040.38
    -4.43 (-0.06%)
     

  • NIKKEI 225

    37,956.59
    -503.49 (-1.31%)
     

  • CAD/EUR

    0.6817
    -0.0002 (-0.03%)
     

Today's Research Reports on Fennec Pharmaceuticals, Baylin Technologies, Canopy Growth and CardioComm Solutions

ACCESSWIRE

NEW YORK, NY / ACCESSWIRE / November 27, 2018 / The Market Edge strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://marketedgereport.com and get exclusive access to our numerous research reports and market updates.

The Market Edge Initiates Coverage on:

Fennec Pharmaceuticals Inc.
https://marketedgereport.com/report/FRX.TO/

Baylin Technologies Inc.
https://marketedgereport.com/report/BYL.TO/

Canopy Growth Corporation
https://marketedgereport.com/report/WEED.TO/

CardioComm Solutions, Inc.
https://marketedgereport.com/report/EKG.V/

ADVERTISEMENT

Fennec Pharmaceuticals’ stock moved 2.42% lower Monday, to close the day at $8.88. The stock recorded a trading volume of 210 shares, which was below its three months average volume of 1,895 shares. In the last year, Fennec Pharmaceuticals' shares have traded in a range of 7.90 - 18.86. The share price has gained 12.41% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $9.55 is lower than its 200-day moving average of $12.00. Shares of Fennec Pharmaceuticals have fallen approximately 28.9 percent year-to-date.

Access The Market Edge's Fennec Pharmaceuticals Inc. Research Report:
https://marketedgereport.com/report/FRX.TO/

On Monday, shares of Baylin Technologies recorded a trading volume of 26,200 shares, which was below the three months average volume of 31,982 shares. The stock ended the day 1.94% higher at $3.67. The share price has fallen 14.45% from its 52week high with a52 week trading range of 2.36 - 4.29. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $3.73 is greater than its 200-day moving average of $3.53. Shares of Baylin Technologies have gained approximately 6.69 percent year-to-date.

Access The Market Edge's Baylin Technologies Inc. Research Report:
https://marketedgereport.com/report/BYL.TO/

Canopy Growth’s stock moved 6% lower Monday, to close the day at $41.71. The stock recorded a trading volume of 2,743,794 shares, which was below its three months average volume of 6,096,801 shares. In the last year, Canopy Growth's shares have traded in a range of 17.16 - 76.68. The share price has gained 143.07% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $53.39 is greater than its 200-day moving average of $47.42. Shares of Canopy Growth have gained approximately 40.25 percent year-to-date.

Access The Market Edge's Canopy Growth Corporation Research Report:
https://marketedgereport.com/report/WEED.TO/

On Monday, shares of CardioComm Solutions recorded a trading volume of 56,000 shares, which was below the three months average volume of 105,274 shares. The stock ended the day flat at $0.04. The share price has fallen 42.86% from its 52week high with a52 week trading range of 0.04 - 0.07. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $0.04 is lower than its 200-day moving average of $0.05. Shares of CardioComm Solutions have fallen approximately 20 percent year-to-date.

Access The Market Edge's CardioComm Solutions, Inc. Research Report:
https://marketedgereport.com/report/EKG.V/

Our Actionable Research on Fennec Pharmaceuticals Inc. (TSX:FRX.TO), Baylin Technologies Inc. (TSX:BYL.TO), Canopy Growth Corporation (TSX:WEED.TO) and CardioComm Solutions, Inc. (TSXV:EKG.V) can be downloaded free of charge at The Market Edge.

The Market Edge

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

The Market Edge has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of MarketEdgeReport.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. MarketEdgeReport.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.marketedgereport.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

The Market Edge, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@marketedgereport.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: The Market Edge